Posted
10/05/2007
EnGenCore opens
with cutting edge
DNA-analyzing instruments
By
Chris Horn
The
University's newest research lab—the
Environmental Genomics Core
Facility—is now open for business, its gleaming array of DNA-analyzing
instruments second to none in the Southeast.
The facility, dubbed EnGenCore by its staff, is located on the fourth
floor of the Arnold School's Public Health Research Center and focuses
on gene expression and gene discovery. The University research community
has first priority in using the facility; EnGenCore is also open to
outside users, and a sliding-scale fee for use is being established.
One of EnGenCore's biggest draws is a next-generation genome sequencing
instrument capable of large-scale projects.
"The Roche Genome Sequencer FLX is our pride and joy," said
Sean Norman,
an environmental health sciences faculty member and interim director of EnGenCore. "It can sequence a bacterial genome in seven
hours—one-hundred million bases. That would take several weeks if not
months on a standard piece of equipment. We're the only lab in South
Carolina with this instrument, one of only a handful in the world."
To
handle the massive amounts of data that the genome sequencer generates,
a Linux-based computer cluster with 64 2.2 GHz processors is set up with
appropriate software for analysis. The genome sequencer, computer
cluster, and other instruments were purchased through the
legislature-funded Freshwater Environmental Initiative and upon the
recommendation of the University's Environmental Research Initiatives
Committee.
On the environmental front, scientists studying the state's
rivers and other ecosystems will be able use the lab to determine the
genetic effects of pollutants on organisms and explore other genetic
issues in the environment. But the scope of scientific questions the
facility can address extends much further.
Phil Buckhaults, a School of Medicine faculty member and scientist at
the S.C. Cancer Center, has used EnGenCore to identify 100 new genes
related to cancer development in the breast and colon.
"If you look at a dozen metastatic tumors and a dozen non-metastastic
tumors and find the same gene in the metastatic tumors, you know that
gene is responsible for metastasis," he said. "That would have taken
many, many months the old-fashioned way—this machine did it overnight."
Discovering the new genes is an important scientific discovery—Buckhaults'
findings have been published in a major journal—but the future
implications are even more important, he said. "This methodology will
revolutionize the way cancer patients are diagnosed and improve the
information from which treatment decisions are made," Buckhaults said.
"It will be a tremendous aid to oncologists as they look at the
individual needs of each cancer patient."
Tara Sabo-Attwood, an environmental health sciences faculty member, is
using another instrument in the facility—the Affymetrix microarray
platform—to probe the entire human genome for changes in the expression
of gene transcripts associated with toxicity of nanoparticles to better
understand their potential human health impacts.
Norman has used the facility to complete the first-draft genome sequence
of a sulfate-reducing bacterium. Identifying the genome composition will
help scientists understand how the bacteria functions in natural
ecosystems where it is involved in the biodegradation of pollutants and
global biogeochemical cycles.
Other potential users of EnGenCore include pharmaceutical companies,
biotechnology firms, hospital systems, and environmental consulting
scientists.
Joe Jones, currently a scientist at Monterrey Bay Research Aquarium, has
been named permanent director of EnGenCore and will start work in
October. To learn more about the facility, go to
www.sph.sc.edu/engencore
or contact Norman at 803-777-0940.
|